Filing Flows › HeartSciences (HSCS) › Q2 FY26 › vs Q1 FY26
HeartSciences (HSCS) Q2 FY26 vs Q1 FY26 (quarter over quarter)
HeartSciences's revenue rose $1K (+27%) from $2K in Q1 FY26 to $2K in Q2 FY26.
HeartSciences, Q2 FY26: revenue $2K, net loss $2.4M, operating cash flow −$2.3M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $2K | $2K | $1K | +27% |
| Net loss | $2.4M | $2.1M | $296K | +14% |
| Costs & expenses | $2.4M | $2.1M | $296K | +14% |
| Operating costs | $2.1M | $1.9M | $200K | +11% |
| Interest & other, net | $277K | $181K | $96K | +53% |
| Cost of revenue | $1K | $1K | $248 | +33% |
| Research & development | $727K | $997K | −$270K | -27% |
| SG&A | $1.3M | $878K | $470K | +53% |
| Operating cash sources | $2.8M | $2.1M | $643K | +30% |
| Depreciation | $7K | $7K | −$105 | -1% |
| Share-based compensation | $437K | $175K | $262K | +150% |
| Cash used in operations | $2.3M | $2.0M | $381K | +19% |
| Net loss absorbed | $2.4M | $2.1M | $296K | +14% |
| Working capital & other | $427K | $80K | $347K | +434% |
Questions
How much did HeartSciences's revenue grow quarter over quarter in Q2 FY26?
HeartSciences's revenue rose $1K (+27%) from $2K in Q1 FY26 to $2K in Q2 FY26.